secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001641172-25-015410
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology raises ~$329K via warrant exercise inducement at reduced $1.50/share
--------------------------------------------------------------------------------

- On June 17, 2025, MAIA entered inducement letters with holders of four warrant series to exercise for cash at reduced exercise price of $1.50 per share.
- Total warrants exercised: 219,283 shares; expected gross proceeds of approximately $328,925.
- Closing expected on or about June 18, 2025; proceeds for general corporate purposes.
- Shares issued as restricted securities exempt under Section 4(a)(2), Rule 506, and/or Section 3(a)(9) of the Securities Act.
- Participating holders include Pre-IPO, March 2024, November 2024, and December 2024 warrant holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225015410/0001641172-25-015410-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225015410/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015410

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer